DustinADemingMD

Oncology • Madison, WI

Physician

Join to view full profile

Dr. Deming is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Deming's full profile

Already have an account?

Office
600 Highland Ave
Madison, WI 53792
Phone+1 608-265-1700

Fax+1 608-890-7127

Education & Training

University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 2010 - 2012
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 2007 - 2010
University of Wisconsin School of Medicine & Public HealthClass of 2007

Certifications & Licensure

WI State Medical License 2009 - 2025
American Board of Internal Medicine Medical Oncology

Clinical Trials

Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver Start of enrollment: 2020 Mar 16
Active, not recruiting
Phase 2
Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04) Start of enrollment: 2020 Jun 23
Active, not recruiting
Phase 1, Phase 2
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

Phase I/II Trial of Perioperative Avelumab in Combination With Chemoradiation in the Treatment of Stage II/III Resectable Esophageal and Gastroesophageal Junction Cancer.
Nataliya V Uboha, Mustafa M Basree, Jens C Eickhoff, Dustin A Deming, Kristina Matkowskyj
Journal of Surgical Oncology. 2025-01-05
The dichotomous roles of microbial-modified bile acids 7-oxo-DCA and isoDCA in intestinal tumorigenesis.
Xingchen Dong, Fei Sun, Henry Secaira-Morocho, Alisa Hui, Ke Wang
Proceedings of the National Academy of Sciences of the United States of America. 2024-11-19
Cancer-Associated Fibroblast Proteins as Potential Targets against Colorectal Cancers.
Ruchi Shah, Katherine A Johnson, Anna E L Lippert, Sean G Kraus, Philip B Emmerich
Cancers. 2024-09-14

Lectures

Biomarkers and New Approaches in Anorectal Cancer
2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018

Press Mentions

Monitoring ctDNA After Colorectal Cancer SurgeryFebruary 2nd, 2023
Cell-Free, Worry-Free: $10,000 Grant Expands Free Access to Personalized Cancer TestFebruary 28th, 2020
UW Carbone Experts Lead Sessions at World's Largest Cancer MeetingMay 31st, 2018
Join now to see all